Analysis of the functions and efficacy of Japan’s Anamorelin

Anamorelin (Anamorelin) is a selective growth hormone-releasing peptide (ghrelin receptor) agonist. By simulating the effect of the endogenous hunger hormone ghrelin, it stimulates the hypothalamic-pituitary-growth hormone axis and promotes the secretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), thereby improving energy metabolism and muscle protein synthesis. This mechanism allows anamorelin to not only increase appetite but also increase lean body mass and muscle mass, thereby alleviating the cachexia state common in cancer patients.

In clinical studies in Japan, anamorelin has been widely used in patients with advanced non-small cell lung cancer and gastric cancer. Its significant effects include increasing appetite, improving weight loss, enhancing physical endurance, and improving overall quality of life. By targeting the core link of metabolic abnormalities and weight loss, the drug solves the problem of cachexia that is difficult to improve with traditional nutritional intervention or oral supplements. The oral administration method makes it convenient for patients to use it for a long time, has high compliance, and does not require complex injections or special operations, providing a simpler solution for clinical use.

In addition, anamorelin exhibits dual effects in regulating energy metabolism and protein synthesis. By increasing lean body mass, it improves muscle function and daily activity capabilities, and also has a certain positive regulatory effect on the metabolism of adipose tissue, helping patients maintain weight and metabolic balance. Studies have shown that anamorelin can significantly increase IGF-1 levels, promote protein synthesis, and show potential benefits in improving metabolic function. This not only relieves cachexia symptoms, but may also improve patients' tolerance during chemotherapy or radiotherapy, improving the overall treatment effect.

In summary, anamorelin provides a scientific, effective and long-term intervention method for patients with advanced cancer through its multi-dimensional mechanism of action. Not only does it show positive results in improving appetite and weight, it also provides significant clinical value in improving muscle function, ability to perform daily activities, and overall quality of life.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/